Intended for healthcare professionals

Practice NIHR Signals

Telephone or internet delivered talking therapy can alleviate irritable bowel symptoms

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l4962 (Published 04 November 2019) Cite this as: BMJ 2019;367:l4962

Editorial

NIHR’s research signals in The BMJ

  1. Rob Cook, clinical director1,
  2. Peter Davidson, clinical advisor2,
  3. Rosie Martin, clinical specialist1
  4. on behalf of NIHR Dissemination Centre
  1. 1Bazian, Economist Intelligence Unit healthcare, London, UK
  2. 2Wessex Institute, University of Southampton, Southampton, UK
  1. Correspondence to R Cook rob.cook{at}bazian.com

The study

Everitt H, Landau G, Little P. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT. Health Technol Assess 2019;23:1-154.

This project was funded by the NIHR Health Technology Assessment Programme (project number 11/69/02).

To read the full NIHR Signal, go to https://discover.dc.nihr.ac.uk/content/signal-000784/irritable-bowel-syndrome-helped-by-telephone-or-internet-cbt

Why was the study needed?

Irritable bowel syndrome affects up to 10% to 20% of the population. Symptoms include bloating, constipation, and diarrhoea. There is no cure, and people with the condition often experience recurrent flare-ups.

Usual treatment includes maintaining a healthy lifestyle and medication such as laxatives and antispasmodics. Face-to-face cognitive behavioural therapy has been shown to help, but NHS availability is limited, and some people find it difficult to attend appointments. Remote delivery options, such as web and telephone therapy, can help overcome these barriers, but their effectiveness has yet to be established for irritable bowel symptoms. This large study helps add to the evidence base.

What did the study do?

This randomised controlled trial included 558 people with irritable bowel syndrome that had not responded to usual treatment. They were recruited from 74 general practice surgeries and three gastroenterology outpatient clinics.

People were randomised to receive treatment as usual or in addition to telephone or web based therapy. The content was aimed at fostering healthy eating patterns, managing stress, and reducing focus on symptoms. The telephone arm received a self help manual and eight hours of telephone therapist support. The web participants received online access to an interactive website and 2.5 hours of telephone therapist support. Assessments were undertaken at baseline, 3, 6, and 12 months.

Limitations of this trial include the higher than ideal dropout rate, which may mean that the true benefit is smaller than it appears. The low rates of participation from eligible people may mean that many people are unwilling to try, or stick with this talking therapy, limiting its feasibility to be used more widely.

What did it find?

• According to the irritable bowel symptom severity score (IBS-SSS)—a scale of 0 (not affected) to 500 (severe)—all groups saw a sustained reduction in symptoms at 12 months. The telephone cognitive behavioural therapy group fell 61.6 points lower than the usual treatment group (95% confidence interval 33.8 to 89.5), and the web cognitive behavioural therapy group 35.2 points lower than the usual treatment group (95% confidence interval 12.6 to 57.8). Authors previously determined that a 35 point change between the groups was clinically significant.

• The primary outcome was also measured by the work and social adjustment scale, scored between 0 (not affected) and 40 (severely affected). A slight improvement was seen in the treatment as usual group; scores improved from 12.4 to 10.8. Scores in the telephone cognitive behavioural therapy group improved to 3.5 points lower than treatment as usual (95% confidence interval 1.9 to 5.1) and the web cognitive behavioural therapy group 3.0 points lower than the usual treatment group (95% confidence interval 1.3 to 4.6).

• Telephone cognitive behavioural therapy had greater adherence rates, with 84% of patients meeting the threshold for adherence, compared with 70% in the web cognitive behavioural therapy arm.

• More adverse events were seen in the cognitive behavioural therapy groups: 77 in the telephone arm, 61 in the web arm, and 55 in the treatment as usual arm. Authors attribute this to the therapist reporting protocol.

• Compared with treatment as usual, the incremental cost-effectiveness ratio was £22 824 for telephone cognitive behavioural therapy and £7724 for web cognitive behavioural therapy.

What does current guidance say on this issue?

The 2008 guideline from the National Institute for Health and Care Excellence on the management of irritable bowel syndrome recommends dietary and lifestyle changes, such as increasing physical activity.

Laxatives and other medications may also be prescribed, and if these do not work, antidepressants can be given as they can help reduce pain. If the above treatments do not improve symptoms after 12 months, people can be referred for psychological treatment such as cognitive behavioural therapy.

What are the implications?

Although a promising alternative to traditional face-to-face cognitive behavioural therapy, web and telephone delivered therapy still requires trained therapist input.

Therapists working in the Improving Access to Psychological Therapies services may already possess the required skills, but this does not address the additional therapist hours needed.

It may be that further research pinpointing the most effective cognitive behavioural therapy elements for these disabling symptoms is necessary to help focus resources further.

Footnotes

  • Contributors: Joelle Kirby

  • All authors contributed to development and review of this summary, as part of the wider NIHR Signals editorial team. RC is guarantor.

  • Disclaimer NIHR Signals are owned by the Department of Health and Social Care and are made available to the BMJ under licence. NIHR Signals report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Signals.

  • Permission to reuse these articles should be directed to disseminationcentre@nihr.ac.uk.

  • Competing interestsThe BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none

  • Further details of The BMJ policy on financial interests is here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests

References